GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Inventories, Finished Goods

EGEIRO Pharma (XPAR:ALVET) Inventories, Finished Goods : €0.12 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Inventories, Finished Goods?

EGEIRO Pharma's quarterly finished goods increased from Dec. 2022 (€0.08 Mil) to Jun. 2023 (€0.12 Mil) but then stayed the same from Jun. 2023 (€0.12 Mil) to Dec. 2023 (€0.12 Mil).

EGEIRO Pharma's annual finished goods declined from Dec. 2021 (€0.13 Mil) to Dec. 2022 (€0.08 Mil) but then increased from Dec. 2022 (€0.08 Mil) to Dec. 2023 (€0.12 Mil).

EGEIRO Pharma Inventories, Finished Goods Historical Data

The historical data trend for EGEIRO Pharma's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Inventories, Finished Goods Chart

EGEIRO Pharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
- - 0.13 0.08 0.12

EGEIRO Pharma Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.08 0.12 0.12 -

EGEIRO Pharma Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

EGEIRO Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Inventories, Finished Goods
Comparable Companies
XPAR:ALVIO XPAR:ALPAT XPAR:ALTAO XPAR:POXEL XPAR:ALOPM XPAR:ALTME XPAR:ALNFL XPAR:AELIS XPAR:ALINT XPAR:ALTHX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041
Website
https://www.egeiro.be
EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines